Skip to content
2000
Volume 23, Issue 12
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Background

Methcathinone, a synthetic cathinone derivative similar to amphetamine, has transitioned from a 1920s ephedrine precursor and Soviet-era antidepressant to a recreationally used substance since the 1970s-1980s, raising public health concerns due to its addiction potential and neurotoxicity-related health risks.

Objective

This review comprehensively analyzes methcathinone's impact on adult offspring, synthesizing recent advancements and critiquing literature to pinpoint key findings, challenges, and future research directions.

Methods

The systematic review adhered to PRISMA guidelines and encompassed case series, prospective and retrospective studies, as well as short communications published in English. An electronic search was conducted on PubMed, Elsevier, and CNKI. The focus was on methcathinone and its neuropsychological disorders and physical health complications, specifically in adult offspring.

Results

A total of 8 studies met the inclusion criteria, resulting in a dataset of methcathinone on neurobehavioral and cognitive functions. These studies mainly found that prenatal methcathinone exposure in rats led to delayed physical development and induced anxiety-like behavior in offspring, with changes observed in neurobehavioral tests and the concentration of serotonin and dopamine. Furthermore, neurochemical effects were identified, showing dose- and time-dependent increases in extracellular dopamine and serotonin concentrations, and neurotoxic potential towards brain dopamine neurons.

Conclusion

This study concludes that methcathinone poses severe risks, including neurotoxicity for users and developmental harm for offspring, necessitating ongoing research to comprehend associated risks and inform public health interventions.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X387589250318041633
2025-03-25
2025-12-26

  • From This Site

    /content/journals/cn/10.2174/011570159X387589250318041633
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. RojekS. KłysM. Maciów-GłąbM. KulaK. StronaM. Cathinones derivatives‐related deaths as exemplified by two fatal cases involving methcathinone with 4‐methylmethcathinone and 4‐methylethcathinone.Drug Test. Anal.201467-877077710.1002/dta.1615 24550156
     [Google Scholar]
  2. EshlemanA.J. WolfrumK.M. HatfieldM.G. JohnsonR.A. MurphyK.V. JanowskyA. Substituted methcathinones differ in transporter and receptor interactions.Biochem. Pharmacol.201385121803181510.1016/j.bcp.2013.04.004 23583454
     [Google Scholar]
  3. MilianoC. SerpelloniG. RimondoC. MereuM. MartiM. De LucaM.A. Neuropharmacology of new psychoactive substances (nps): Focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants.Front. Neurosci.20161015310.3389/fnins.2016.00153 27147945
     [Google Scholar]
  4. HadlockG.C. WebbK.M. McFaddenL.M. ChuP.W. EllisJ.D. AllenS.C. AndrenyakD.M. Vieira-BrockP.L. GermanC.L. ConradK.M. HoonakkerA.J. GibbJ.W. WilkinsD.G. HansonG.R. FleckensteinA.E. 4-Methylmethcathinone (mephedrone): Neuropharmacological effects of a designer stimulant of abuse.J. Pharmacol. Exp. Ther.2011339253053610.1124/jpet.111.184119 21810934
     [Google Scholar]
  5. PantanoF. TittarelliR. MannocchiG. PacificiR. di LucaA. BusardòF.P. MarinelliE. Neurotoxicity induced by mephedrone: An up-to-date review.Curr. Neuropharmacol.201715573874910.2174/1570159X14666161130130718 27908258
     [Google Scholar]
  6. PascoeM.J. RadleyS. SimmonsH.T.D. MeashamF. The cathinone hydra: Increased cathinone and caffeine adulteration in the english MDMA market after brexit and covid-19 lockdowns.Drug Sci. Policy Law202282050324522109920910.1177/20503245221099209
     [Google Scholar]
  7. GuirguisA. CorkeryJ.M. StairJ.L. KirtonS.B. ZlohM. SchifanoF. Intended and unintended use of cathinone mixtures.Hum. Psychopharmacol.2017323e259810.1002/hup.2598 28657191
     [Google Scholar]
  8. HabratB. SilczukA. KlimkiewiczA. Manganese encephalopathy caused by homemade methcathinone (ephedrone) prevalence in poland.Nutrients20211310349610.3390/nu13103496 34684497
     [Google Scholar]
  9. de BieR.M.A. GladstoneR.M. StrafellaA.P. KoJ.H. LangA.E. Manganese-induced parkinsonism associated with methcathinone (Ephedrone) abuse.Arch. Neurol.200764688688910.1001/archneur.64.6.886 17562938
     [Google Scholar]
  10. KoziorowskiD. SzlufikS. MandatT. KłodaM. Duszyńska-WąsK. DrzewinskaA. FriedmanA. Improvement in ephedrone parkinsonism after global pallidus pars interna deep brain stimulation implantation.Mov. Disord. Clin. Pract.20163219119310.1002/mdc3.12248 30713913
     [Google Scholar]
  11. SmithD. NegusS. BloughB. BanksM. Cocaine‐like discriminative stimulus effects of amphetamine, cathinone, and alpha‐pyrrolidinovalerophenone analogs in male rhesus monkeys.FASEB J.201630S11184310.1096/fasebj.30.1_supplement.1184.3
     [Google Scholar]
  12. BuszaJ.R. BalakirevaO.M. TeltschikA. BondarT.V. SeredaY.V. MeynellC. SakovychO. Street-based adolescents at high risk of HIV in Ukraine.J. Epidemiol. Community Health201165121166117010.1136/jech.2009.097469 20864455
     [Google Scholar]
  13. BruntT.M. PoortmanA. NiesinkR.J.M. van den BrinkW. Instability of the ecstasy market and a new kid on the block.Mephedrone. J. Psychopharmacol201125111543154710.1177/0269881110378370 20826554
     [Google Scholar]
  14. YouyouZ. YaleiY. YanfeiD. ShuquanZ. ZhaoyangL. LiangR. LiangL. Effects of methcathinone exposure during prenatal and lactational periods on the development and the learning and memory abilities of rat offspring.Neurotox. Res.2020381869510.1007/s12640‑020‑00184‑2 32140923
     [Google Scholar]
  15. YouyouZ. ZhaoyangL. ChenL. ShuquanZ. HuiW. Effects of prenatal methcathinone exposure on the neurological behavior of adult offspring.Curr. Neuropharmacol.202422132256226210.2174/1570159X22666240128004722 38333971
     [Google Scholar]
  16. StepensA. GromaV. SkujaS. PlatkājisA. AldiņšP. EkšteinaI. MārtiņsoneI. BricisR. DonaghyM. The outcome of the movement disorder in methcathinone abusers: Clinical, MRI and manganesemia changes, and neuropathology.Eur. J. Neurol.201421219920510.1111/ene.12185 23678867
     [Google Scholar]
  17. Angoa-PérezM. KaneM.J. FrancescuttiD.M. SykesK.E. ShahM.M. MohammedA.M. ThomasD.M. KuhnD.M. Mephedrone, an abused psychoactive component of ‘bath salts’ and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum.J. Neurochem.201212061097110710.1111/j.1471‑4159.2011.07632.x 22191803
     [Google Scholar]
  18. AnnekenJ.H. Angoa-PérezM. SatiG.C. CrichD. KuhnD.M. Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine.Neuropharmacology2018134Pt A465610.1016/j.neuropharm.2017.08.033 28851615
     [Google Scholar]
  19. SelikhovaM. FedoryshynL. MatviyenkoY. KomnatskaI. KyrylchukM. KrólickiL. FriedmanA. TaylorA. JägerH.R. LeesA. SanotskyY. Parkinsonism and dystonia caused by the illicit use of ephedrone—A longitudinal study.Mov. Disord.200823152224223110.1002/mds.22290 18785245
     [Google Scholar]
  20. ZhouX. BouitbirJ. LiechtiM.E. KrähenbühlS. MancusoR.V. Hyperthermia increases neurotoxicity associated with novel methcathinones.Cells20209496510.3390/cells9040965 32295288
     [Google Scholar]
  21. ZhouX. BouitbirJ. LiechtiM.E. KrähenbühlS. MancusoR.V. Para-halogenation of amphetamine and methcathinone increases the mitochondrial toxicity in undifferentiated and differentiated sh-sy5y cells.Int. J. Mol. Sci.2020218284110.3390/ijms21082841 32325754
     [Google Scholar]
  22. SuyamaJ.A. SaklothF. KolanosR. GlennonR.A. LazenkaM.F. NegusS.S. BanksM.L. Abuse-related neurochemical effects of para-substituted methcathinone analogs in rats: Microdialysis studies of nucleus accumbens dopamine and serotonin.J. Pharmacol. Exp. Ther.2016356118219010.1124/jpet.115.229559 26645638
     [Google Scholar]
  23. GatchM.B. RutledgeM.A. ForsterM.J. Discriminative and locomotor effects of five synthetic cathinones in rats and mice.Psychopharmacology.201523271197120510.1007/s00213‑014‑3755‑3 25281225
     [Google Scholar]
  24. SparagoM. WlosJ. YuanJ. HatzidimitriouG. TolliverJ. Dal CasonT.A. KatzJ. RicaurteG. Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): A new drug of abuse.J. Pharmacol. Exp. Ther.199627921043105210.1016/S0022‑3565(25)21220‑4 8930215
     [Google Scholar]
  25. StepensA. LoginaI. LigutsV. AldiņšP. EkšteinaI. PlatkājisA. MārtiņsoneI. TēraudsE. RozentāleB. DonaghyM. A Parkinsonian syndrome in methcathinone users and the role of manganese.N. Engl. J. Med.2008358101009101710.1056/NEJMoa072488 18322282
     [Google Scholar]
  26. JuurmaaJ. MenkeR.A.L. VilaP. MüürseppA. TombergT. IlvesP. NigulM. Johansen-BergH. DonaghyM. StaggC.J. StepensA. TabaP. Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndrome.Brain Behav.2016611e0053910.1002/brb3.539 27843694
     [Google Scholar]
  27. EnnokM. SikkK. HaldreS. TabaP. Cognitive profile of patients with manganese-methcathinone encephalopathy.Neurotoxicology20207613814310.1016/j.neuro.2019.10.007 31678058
     [Google Scholar]
  28. MeyerM.R. MaurerH.H. Metabolism of designer drugs of abuse: An updated review.Curr. Drug Metab.201011546848210.2174/138920010791526042 20540700
     [Google Scholar]
  29. Prevention programmes2018Available from: https://www.drugabuse.gov/publications/drugfacts/prevention-programs
  30. McCance-KatzE.F. The substance abuse and mental health services administration (SAMHSA): New directions.Psychiatr. Serv.201869101046104810.1176/appi.ps.201800281 30099944
     [Google Scholar]
/content/journals/cn/10.2174/011570159X387589250318041633
Loading
Neurobehavioral Disorders and Cognitive Impairment in Methcathinone Exposure: A Systematic Review of Literature
Curr. Neuropharmacol. 23, 1575 (2025); https://doi.org/10.2174/011570159X387589250318041633
/content/journals/cn/10.2174/011570159X387589250318041633
/content/journals/cn/10.2174/011570159X387589250318041633
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): adult offspring; brain injury; cognitive impairment; developmental harm; Methcathinone; neurobehavioral tests

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test